Abstract
Demand to grow nearly 6% per year through 2011
US demand for patient monitoring systems is forecast to rise 5.9 percent
yearly to $12 billion in 2012. Advances in wireless and sensor technologies
will bolster growth by leading to the introduction of new equipment and
accessories with enhanced performance capabilities. Patient monitoring
procedures will rise throughout the primary health care sector based on
contributions to improved therapeutic outcomes and efficiencies. The market
for selfmonitoring activities will also expand as chronic care patients,
especially persons with asthma, diabetes and heart disorders, focus greater
attention on preventive care.
Blood glucose test supplies to remain top accessory
Blood glucose testing supplies will continue to dominate sales for patient
monitoring accessories based on upward trends in the prevalence of diabetes
and enhanced efforts by the health care sector to reduce the number of
undiagnosed cases. The expansion of diabetes education programs will encourage
diabetic patients to follow established guidelines for self-testing and
periodic professional examinations, resulting in double-digit gains through
2012. The best opportunities will emerge in electrochemical blood glucose test
strips, which require less blood and yield faster and more accurate results
than older photometer reflectance test strips. The expansion of ECG and other
vital signs monitoring activities in hospitals and outpatient centers, coupled
with the development of advanced generation products based on microchips, will
boost sales of patient monitoring catheters, electrodes and sensors.
Study coverage
It presents historical demand data (1997, 2002, 2007) plus forecasts (2012,
2017) for patient monitoring equipment and accessories by type and market. The
study also assesses market environment factors, evaluates US sales data and
profiles 28 competitors.
View Cart
